IRIS
BALBI, MATILDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.924
AS - Asia 713
NA - Nord America 424
SA - Sud America 59
AF - Africa 15
OC - Oceania 1
Totale 4.136
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.801
US - Stati Uniti d'America 404
SG - Singapore 297
CN - Cina 190
VN - Vietnam 133
HK - Hong Kong 40
BR - Brasile 34
FR - Francia 22
GB - Regno Unito 22
AR - Argentina 15
FI - Finlandia 14
DE - Germania 13
CA - Canada 10
PL - Polonia 9
IN - India 8
JP - Giappone 8
BD - Bangladesh 7
NL - Olanda 6
ES - Italia 5
IQ - Iraq 5
MX - Messico 5
ZA - Sudafrica 5
PH - Filippine 4
SI - Slovenia 4
UA - Ucraina 4
CH - Svizzera 3
EC - Ecuador 3
ID - Indonesia 3
NP - Nepal 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
IE - Irlanda 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
LT - Lituania 2
MD - Moldavia 2
PT - Portogallo 2
RU - Federazione Russa 2
SE - Svezia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
JO - Giordania 1
LB - Libano 1
MA - Marocco 1
MT - Malta 1
NO - Norvegia 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
TR - Turchia 1
YT - Mayotte 1
Totale 4.136
Salva come PNG Salva come JPEG
Città #
Genoa 1.619
Genova 532
Vado Ligure 364
Rapallo 196
Singapore 160
San Jose 133
Ashburn 58
Ho Chi Minh City 43
Hong Kong 40
Beijing 35
Council Bluffs 31
Hanoi 29
Lauterbourg 19
New York 15
Helsinki 13
Bordighera 12
Da Nang 10
Rome 10
St Louis 10
Haiphong 9
Orem 9
Santa Clara 9
Frankfurt am Main 8
Los Angeles 8
Montreal 7
Staten Island 7
Boston 6
São Paulo 6
Baghdad 5
Chicago 5
Milan 5
Piscataway 5
Tokyo 5
Amsterdam 4
Bari 4
Basingstoke 4
Krakow 4
Kyiv 4
Ljubljana 4
London 4
Madrid 4
Mexico City 4
Naples 4
Tianjin 4
Turin 4
Birmingham 3
Buffalo 3
Bến Tre 3
Castellana Grotte 3
Dallas 3
Denver 3
Hải Dương 3
Leipzig 3
Phủ Lý 3
Pisa 3
Sherwood Park 3
Warsaw 3
Zurich 3
Ahmedabad 2
Avezzano 2
Braga 2
Bratislava 2
Buenos Aires 2
Can Tho 2
City of London 2
Curitiba 2
Dublin 2
Houston 2
Johannesburg 2
Nairobi 2
Newark 2
North Bergen 2
Phủ Từ Sơn 2
Poplar 2
Salt Lake City 2
San Salvador 2
Shanghai 2
Tel Aviv 2
Thái Bình 2
Wroclaw 2
Addis Ababa 1
Algiers 1
Amman 1
Arroyo Seco 1
Athens 1
Atlanta 1
Baguio City 1
Belém 1
Bengaluru 1
Berlin 1
Bismarck 1
Biên Hòa 1
Blumenau 1
Boardman 1
Bolton 1
Bridgetown 1
Brooklyn 1
Bình Phước 1
Bắc Giang 1
Bắc Ninh 1
Totale 3.574
Salva come PNG Salva come JPEG
Nome #
Presynaptic GLP-1 receptors enhance the depolarization-evoked release of Glutamate and GABA in the mouse cortex and hippocampus 232
Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer’s disease. 210
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression 177
Group I metabotropic glutamatergic receptors regulating glutamate release and microglia phenotype in a murine model of amyotrophic lateral sclerosis 176
The complex phenotype and function of spinal cord microglia during ALS progression and the impact of metabotropic glutamate receptor type 5 down-regulation in SOD1G93A mice 147
GEBR-32A, A NEW PROMISING PDE4D INHIBITOR FOR TREATMENT OF ALZHEIMER'S DISEASE 133
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 133
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 127
Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis 120
In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS 119
Glucagon Like Peptide-1 increases glutamate release in the mouse cerebral cortex and hippocampus by activacting presynaptic GLP-1R 113
Nearly 30 years of animal models to study amyotrophic lateral sclerosis: A historical overview and future perspectives. 113
Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes 108
Genetic and pharmacological effects by blocking mGlu5 receptor in the SOD1G93A mouse model of amyotrophic lateral sclerosis 105
cGMP MODULATES LONG-TERM POTENTIATION AND MEMORY BY ENHANCING ABETA PRODUCTION 105
Preclinical study showing a gender specific protective properties of conjugated linoleic acid (CLA) for amyotrophic lateral sclerosis 103
Phenotype changes of microglia in SOD1G93A mice after mGluR5 genetic down regulation 102
Reducing mglur5 expression attenuates the reactive phenotype of astrocytes cultured from the spinal cord of late symptomatic SOD1G93A mice 100
In-vivo and in-vitro evidence supporting the role of mGlu5 receptor as a key regulator of glutamate downstream effects in ALS 100
The Physio-Pathological Role of Group I Metabotropic Glutamate Receptors Expressed by Microglia in Health and Disease with a Focus on Amyotrophic Lateral Sclerosis 92
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 82
Therapeutic effects of MSC-derived EVs intranasally administered on ALS mice 81
Multiple approaches reveal altered lipid metabolism, neurotransmitter release and nervous conduction in a zebrafish model of Alexander Disease 80
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells rescue glial activation in in-vitro models of amyotrophic lateral sclerosis 77
PRESYNAPTIC GLP-1 RECEPTORS ENHANCE GLUTAMATE AND GABA RELEASE FROM PURIFIED MOUSE CORTICAL AND HIPPOCAMPAL SYNAPTOSOMES 75
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 71
The mGlu5 receptor negative allosteric modulator CTEP as a pharmacological tool to dampen ALS disease progression: in-vivo preclinical studies and clinical perspectives 69
Combined motor and behavioural tracking approach to stratify ALS progression in SOD1(G93A) mice. 68
Therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 67
In-vitro and in-vivo studies showing the beneficial effects of extracellular vesicles derived from mesenchymal stem cells on the reactive astrocyte activation in amyotrophic lateral sclerosis 67
Partial deletion of mGluR5 affects microglia inflammatory phenotype, bioenergetic characteristics, and red-ox state during ALS progression in SOD1G93A mice 64
Sex-specific motor and behavioural parameters for early stratification of ALS progression in SOD1(G93A) mice. 64
Partial deletion of mGluR5 affects M1 and M2 phenotypes in microglia acutely isolated from SOD1(G93A) mice during disease progression 64
Changes of the microglia phenotype in the SOD1G93A mouse model of amyotrophic lateral sclerosis after mGluR5 genetic down-regulation 63
Synapto-gliosomal characterization in a zebrafish model of Alexander disease 62
Efficacy and Safety of Visible and Near-Infrared Photobiomodulation Therapy on Astenospermic Human Sperm: Wavelength-Dependent Regulation of Nitric Oxide Levels and Mitochondrial Energetics 61
MSC-derived extracellular vesicles for the treatment of ALS 58
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells revert glial activation and neurotoxicity in in-vitro models of amyotrophic lateral sclerosis 56
Preventive effects of conjugated linoleic acid (CLA) in-vivo oral treatment in the SOD1G93A preclinical model of amyotrophic lateral sclerosis 53
Phenotype changes of spinal cord microglia cells acutely purified from SOD1G93AALS mice during disease progression: focus on the genetic down regulation of mGlu5 receptor 52
Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD 51
Chromosomal Deletion Involving ANKRD26 Leads to Expression of a Fusion Protein Responsible for ANKRD26-Related Thrombocytopenia 49
Intranasal in-vivo administration of MSC-derived EVs on ALS mice 49
miR-29a-3p and TGF-β Axis in Fanconi anemia: mechanisms driving metabolic dysfunction and genome stability 43
The partial deletion of mGluR5 affects the pro- and anti-inflammatory and bioenergetic characteristics of microglia during ALS progression in SOD1(G93A) mice 42
The investigational anti-B7-H3 antibody-drug conjugate vobramitamab duocarmazine exerts anti-tumor activity in vitro and in vivo in pediatric sarcoma preclinical models 39
Local Insulin for Local Needs? Insights into Retinal Insulin Signaling and RPE Metabolism 27
null 1
null 1
Totale 4.251
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.174
article - articoli 5.063
book - libri 0
conference - conferenze 7.701
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.938
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 26 11 5
2021/2022182 1 8 13 11 7 10 23 37 17 16 17 22
2022/2023245 24 20 7 19 21 28 2 22 50 6 44 2
2023/2024301 6 23 23 32 29 48 19 18 4 20 28 51
2024/20251.045 56 47 24 80 105 93 107 183 33 68 109 140
2025/20262.072 246 79 171 184 314 114 310 198 247 209 0 0
Totale 4.251